Shares of Viatris Inc. VTRS rose 1.56% to $7.81 Wednesday, on what proved to be an all-around great trading session for the ...

We recently published a list of the 10 Best Cheap Stocks to Buy Under $10. In this article, we are going to take a look at ...

New York, New York-- (Newsfile Corp. - April 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain ...

(Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve claims by U.S. state and local governments that it fueled an epidemic of ...

Investor Deadline: Investors who purchased or acquired VIATRIS securities during the Class Period may, no later than JUNE 3, 2025, seek to be appointed as a lead plaintiff representative of the class.

Viatris seeks Japan’s MHLW approval for Effexor SR capsules to treat generalized anxiety disorder: Pittsburgh Tuesday, April 22, 2025, 13:00 Hrs [IST] Viatris Inc., a global hea ...

Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer.

Learn more about whether Ligand Pharmaceuticals Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Monday said it has submitted Supplemental New Drug Application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Effexor to treat ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Viatris Inc. (NASDAQ: VTRS) securities between August 8, 2024 and February ...

Shares of Viatris Inc. VTRS advanced 1.59% to $7.69 Tuesday, on what proved to be an all-around great trading session for the ...